Hybrid
Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists.
Our CEO Gregg Siegal attended the event and participated in many interesting and educational discussions.